P.M.A. Calverley (Liverpool, United Kingdom), M. Kneussl (Vienna, Austria), G. Huchon (Paris, France), P. Albert (Chester, United Kingdom)
LATE-BREAKING ABSTRACT: Evaluation of symptoms and risk on stable chronic obstructive pulmonary disease patients with radiographic bronchiectasis
R. B. ZHANG, F. YUAN, X. Y. TAN, Y. CUI, Q. Y. HE (beijing, China)
|  |
LATE-BREAKING ABSTRACT: Multidimensional assessment of patients with chronic obstructive pulmonary disease
R. Aguiar, A. Mendes, M. J. Valente, S. Valente (Lisbon, Covilhã, Portugal)
|  |
LATE-BREAKING ABSTRACT: Clinical and Epidemiological Characteristics of Hospitalized COPD Exacerbations.
J. Gjerazi, E. Tashi, S. Telo, A. Tanka, E. Ndreu, E. Nushi, O. Petre, R. Kore, J. Beli, P. Kapisyzi (Fier, Tirana, Albania)
| |
The mechanisms of antiinflammatory effect of mucolytic therapy
U. Farkhutdinov, V. Petryakov, R. Farkhutdinov (Ufa, Russian Federation)
| |
Mortality predictors in stable COPD
H. Azcuna, C. Esteban, I. Arostegi, J. Moraza, M. Aburto, A. Aramburu, M. Egurrola (Usansolo, Spain)
| |
Pharmacologic bronchodilation response to salbutamol in COPD patients
F. Mansouri, M. H. Boskabady (Kermanshah, Mashad, Islamic Republic Of Iran)
| |
Biomarkers in COPD exacerbation, the role of adiponectin
V. Vitsas, M. Kardara, A. Koutsoukou, P. Michalopoulou, S. Orfanos, G. Tsoukalas, A. Kotanidou (Athens, Greece)
| |
Chronic obstructive pulmonary disease and myocardial infarction: Special aspects of clinical course in comorbid conditions
L. Rasputina, Y. Mostovoy, V. Cherbak, A. Rasputina, H. Demchuk, I. Gncharova (Vinnytsia, Ukraine)
| |
Mukoregulatory drugs in treating COPD
A. Zhumagalyieva, L. Karazhanova (Semey, Kazakhstan)
| |
Effect of roflumilast on morphological changes in mucous membrane of bronchi in patients with severe chronic obstructive pulmonary disease
M. Ostrovskyy, I. Savelikhina, O. Varunkiv, M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine)
| |
Clinical, functional and laboratory assessment of treatment efficacy in COPD patients
I. Baranova, I. Leshchenko (Yekaterinburg, Russian Federation)
| |
The characterization of diastolic function of the right ventricle in patients with COPD combined with congestive heart failure (CHF)
V. Abdullayev, G. Aliyeva, R. Yusifov (Baku, Azerbaijan)
| |
Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD
K. Gashynova (Dnipropetrovs'k, Ukraine)
| |
Comorbidity at COPD - is actual problem of pulmonology
Y. Mostovoy, T. Konstantynovych, L. Rasputina, M. Ovcharuk, A. Dovgan (Vinnytsia, Ukraine)
| |